Fernando Perez-Villatoro

Genes, computers, and Rock'n Roll 🧬
PhD student in @SystemTumor lab. A human/dancer.

[Fernando Perez-Villatoro @FrandoPV]

Next Friday May 9th I'll be defending my doctoral thesis, about biomarker discovery in #ovariancancer using computational integrative methods.
I'm very grateful to all my colleagues, my mentor @afarkkila, @iCAN_Finland and @SystemTumor

[iCAN - Digital Precision Cancer Medicine @iCAN_Finland]

https://t.co/3P9Pknz2Fe

[Fernando Perez-Villatoro @FrandoPV]

It's incredibly rewarding to be part of these research projects and contribute to improving clinical care for #OvCan patients.
Read more about my #PhD projects 👇 🖥️#WorldOvarianCancerDay

[FarkkilaLab @SystemTumor]

(1/5) I'm @FrandoPV, a PhD student working in the @SystemTumor lab at @helsinkiuni. I perform 💻analysis of both the structure of the genome and the tumor microenvironment in #OvCan to discover biomarkers that could guide its treatment. Excited to share insights about this!

[María Mercedes Hincapié @MariaMHincapie]

@TumorBoardTues @afarkkila @IntegrityCE 7/16 #TumorBoardTuesday
🔍Mini Tweetorial 4: Defining HRD tumors🔍
🧬Previous algorithms e.g. Telli2016 combined breast and ovarian samples, hindering precise HRD identification
🔍 #ovaHRDscar: game-changer in HRD detection and patient stratification https://t.co/hqt6F7qtkv

[María Mercedes Hincapié @MariaMHincapie]

@TumorBoardTues @afarkkila @IntegrityCE 8/16 #TumorBoardTuesday
🔍Mini Tweetorial 5: #ovaHRDscar🔍
🔬By @FrandoPV @SystemTumor & team: optimized criteria to identify HGSC HRD tumors beyond BRCAmut
📈#ovaHRDscar is now used for centralized testing of OvCan patients in 🇫🇮 to guide PARPi treatments @HUS_fi @HelsinkiUniMed

[Fernando Perez-Villatoro @FrandoPV]

Really honored for the opportunity to present our work at the EACR-Cancer-Multiomics-and-Computational-Biology special conference.
Thanks @EACRnews, our collaborators and to my mentor @afarkkila

[Fernando Perez-Villatoro @FrandoPV]

Looking forward to this EACR conference to get to know more interesting advances in the field. I'll be having a short talk presenting part of my PhD work. Eager to brainstorm and exchange ideas with the EACR community.

[EACR @EACRnews]

There are still TWO WEEKS left to register for Cancer Genomics, Multiomics and Computational Biology!

Don't miss one of our most popular conferences, taking place this year in Bergamo: https://t.co/vfe31jdjED

[Fernando Perez-Villatoro @FrandoPV]

How can we enhance the utility of models in clinics? This is an excellent article on the subject.

[Florian Markowetz @markowetzlab]

All models are wrong and yours are useless!

In case you missed my talk yesterday on how to make clinical prediction tools useful for patients, you can read all about it here.

Enjoy!

https://t.co/WAG8yz1y65

[Anniina Färkkilä @afarkkila]

Interested in spatial tumor immunology?Unique opportunity to join our Lab! Please share! https://t.co/m5Rpo4lfHo https://t.co/1qbf89ljaM @HiLIFE_helsinki @FIMM_UH @HelsinkiUniMed @iCAN_Finland

[Anna Vähärautio @AnnaVaharautio]

How do #cancer cells with resistant fates differ from the sensitive, already before the treatment? To answer this, we developed ReSisTrace, a cellular time-travel method that uses the similarity of sister cells to trace back pre-existing resistance. https://t.co/gqmuK9mu51

[FarkkilaLab @SystemTumor]

Last night's #Färkkilab pikkujoulu was epic! 🎉 December vibes and a potluck with flavors from around the globe 🌍🍲. A lab that eats together, stays together! 👩‍🔬👨‍🔬

[Fernando Perez-Villatoro @FrandoPV]

I'm really honored and thrilled to be awarded by The Cancer Society of Finland (@Syopasaatio) the dissertation/incentive grant. Thanks and thanks to my mentor @afarkkila.

[Syöpäsäätiö @Syopasaatio]

Syöpäsäätiön vuosittain saamilla lahjoitusvaroilla tuetaan monipuolisesti syövän tutkimushankkeita. Syöpäsäätiö jakaa nyt 75-vuotisjuhlavuotenaan syöpätutkimukseen apurahoja ennätykselliset 7,5 miljoonaa euroa. Lue lisää täältä 👉https://t.co/tk1jqQpAU3 #syöpätutkimus #apurahat

[Anniina Färkkilä @afarkkila]

@SystemTumor Lab highlighted in flash talks by @FrandoPV and @adajnq 💪🏼#AACRovc23

[Dream3D Lab @Dream3DLab]

For this #FluorescenceFriday we bring a trhowback to one of our iconic serial killer T cells in honor of all the great work performed on understanding and enhancing T cell #immunotherapy using #LiveCellImaging for #CancerResearch

[Professor Booty PhD @ProfBootyPhD]

I think we need to talk about how devastating this cancer microbiome refutation paper from
@StevenSalzberg1
and colleagues is. It really speaks to how devoid of critical thinking and intellectual depth our glam publishing ecosystem has become. 1/n
https://t.co/wWsHTa4K8x

[Anniina Färkkilä @afarkkila]

Congrats @FrandoPV for great
talk at the #rpuscienceday2023 #oncosys #ovariancancer #CancerResearch

[Anniina Färkkilä @afarkkila]

Excited to start #EASimmuneresponses With @Dr_Alfredo_ @FrandoPV and Ashwini presenting our work!

[Anniina Färkkilä @afarkkila]

Our work highlighted in the Finnish tabloid #iltalehti! Glad to see promotion of #ovariancancer awareness and information on PARP inhibitors to the public and #patients @Syopapotilaat @iCAN_Finland

[Fernando Perez-Villatoro @FrandoPV]

@afarkkila Our original article is available here: https://t.co/oBgkiDiIFe

[Fernando Perez-Villatoro @FrandoPV]

My behind the paper -blog post titled "Ovarian cancer specific homologous recombination deficiency score" is available here:
https://t.co/XO1yFuLPAD
Check the description and relevance of our latest article.
Thanks @afarkkila and all collaborators for the support.

[Anniina Färkkilä @afarkkila]

I am happy to share our recent work on an optimized HRD test for #ovarian cancer! Importantly, #ovaHRDscar is already implemented into the clinics @HUS_fi as basis for treatment with PARP inhibitors. @HelsinkiUniMed @nsgo_org https://t.co/tfbMnA0eRb